Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArbuthnot Regulatory News (ARBB)

Share Price Information for Arbuthnot (ARBB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,025.00
Bid: 990.00
Ask: 1,060.00
Change: 0.00 (0.00%)
Spread: 70.00 (7.071%)
Open: 1,025.00
High: 0.00
Low: 0.00
Prev. Close: 1,025.00
ARBB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Hardman & Co Research on Arbuthnot Banking Group (ARBB) 2022: profits and growth in core and new franchises

6 Apr 2023 12:15

Hardman & Co Research Hardman & Co Research on Arbuthnot Banking Group (ARBB) 2022: profits and growth in core and new franchises 06-Apr-2023 / 12:15 GMT/BST The issuer is solely responsible for the content of this announcement.


Hardman & Co Research on Arbuthnot Banking Group (ARBB):2022: profits and growth in core and new franchises 

ABG’s 2022 results delivered the expected strong profit and franchise growth (pre-tax profit up from £4.6m to £20m). Core business profitability increased primarily because of widening spreads increasing the value of deposits. Core credit quality remained good. The scale of growth has been driven by the way in which ABG has managed its franchise, building a relationship bank with less price-sensitive deposits. In recent years, ABG has invested in multiple, new, specialised SME financing businesses. These delivered franchise/profit growth in 2022. There is no Silicon Valley Bank (SVB) read-across. The dividend rose by more than expected, and the medium-term Return on Capital (RoC ) target was achieved early.

 

Please click on the link below for the full report:

https://hardmanandco.com/research/corporate-research/2022-profits-and-growth-in-core-and-new-franchises/

If you are interested in meeting the company, you can register your interest by clicking on the above link

To contact us:

Hardman & Co1 Frederick’s Place

London

EC2R 8AE

www.hardmanandco.com

Follow us on Twitter @HardmanandCo

Contact:

Mark Thomas

+44(0)203 693 7075

 

mt@hardmanandco.com 

Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement.

About Hardman & Co: Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259. Attention is drawn to the important disclaimers at the end of the report.


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

1603289 06-Apr-2023 

corporate announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
16th Oct 20197:00 amRNSThird Quarter Trading Update
10th Sep 20194:16 pmRNSTransaction in own shares
5th Sep 201912:42 pmRNSChange of Auditor
8th Aug 20195:03 pmRNSCompletion of Mortgage Portfolio Acquisition
29th Jul 20193:35 pmEQSHardman & Co Research: Arbuthnot Banking Group (ARBB): 1H'19 results: diversified, low-risk growth continues
17th Jul 20197:00 amRNSHalf Year Results
3rd Jul 20193:05 pmEQSHardman & Co Research: Arbuthnot Banking Group (ARBB): Mortgage portfolio acquisitions
3rd Jul 20197:00 amRNSMortgage Portfolio Acquisition
3rd Jun 20194:35 pmRNSNew £25 million (Tier 2 qualifying) loan
3rd Jun 20197:00 amRNSAppointment of non-executive director
17th May 20195:11 pmRNSDirector/PDMR Shareholding
17th May 20197:00 amRNSAdmission to NEX, First Day of Dealings
9th May 20194:05 pmRNSAnnual General Meeting Statement
1st May 20197:00 amRNSChange of Advisers
1st May 20197:00 amRNSProposed NEX Admission and Non-Voting Share Issue
30th Apr 20197:15 amEQSHardman & Co Research: Arbuthnot Banking Group (ARBB): 2018 results: growth and diversity
12th Apr 201911:54 amRNSHolding(s) in Company
12th Apr 20197:30 amRNSResult of sale of ordinary shares in Secure Trust
11th Apr 20194:35 pmRNSProposed sale of ordinary shares in Secure Trust
28th Mar 20197:00 amRNSFinal Results
21st Feb 20197:00 amRNSPre Close Trading Update
26th Nov 20182:56 pmRNSHolding(s) in Company
22nd Oct 20181:57 pmRNSHolding(s) in Company
17th Oct 20187:00 amRNSThird Quarter Trading Update
8th Aug 20189:48 amRNSDirectorate Change
26th Jul 20181:50 pmEQSHardman & Co Research: Arbuthnot Banking Group (ARBB): 1H'18 results: continuing the good work
17th Jul 20187:00 amRNSHalf Year Report
11th Jul 20187:00 amRNSAppointment of New Chief Executive Officer
10th May 20183:26 pmRNSAGM Statement
17th Apr 20183:23 pmRNSBoard Change
4th Apr 201811:15 amRNSHardman & Co: 2017: capital deployed, adding value
28th Mar 20187:00 amRNSFinal Results
22nd Feb 20187:00 amRNSPre close Trading Update
11th Oct 20177:00 amRNSArbuthnot Banking Group 3Q Trading Update
27th Jul 201711:35 amRNSHardman Research: Value added strategy in results
18th Jul 20177:00 amRNSHalf-year Report
4th May 20173:29 pmRNSAnnual General Meeting Statement - 2017
28th Apr 201711:20 amRNSCompletion of Acquisition
30th Mar 20175:03 pmRNSDirector/PDMR Shareholding
28th Mar 20171:29 pmRNSHardman Research: History is repeating itself
23rd Mar 20177:00 amRNSFinal Results for the year to 31 December 2016
21st Feb 20177:00 amRNSPre Close Trading Update
23rd Jan 20175:58 pmRNSDirector/PDMR Shareholding
23rd Jan 20173:27 pmRNSDirector/PDMR Shareholding
22nd Dec 201612:26 pmRNSHardman Research: Clear strategy, value added deal
20th Dec 20165:10 pmRNSAsset Backed Finance Acquisition
19th Dec 20167:00 amRNSLoan Portfolio Acquisition
9th Dec 201611:12 amRNSChange of Adviser
18th Oct 20169:36 amRNSHardman&Co. Special dividend, accelerated investm.
13th Oct 20167:00 amRNSThird Quarter Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.